SCHEMBL22116343

SCHEMBL22116343

COC1CCN(c2cccc(S(=O)(=O)NC(=O)C3CC3)n2)C1

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 18/20 0.46
▸ TYK2 P29597 1/20 0.41
▸ KIF18A Q8NI77 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22116414 0.84 ABL1 (0.43) ACACBKIF18A
SCHEMBL22116366 0.84 ABL1 (0.43) ACACBKIF18A
SCHEMBL30611688 0.84 ABL1 (0.43) ACACBKIF18A
SCHEMBL30611680 0.84 ABL1 (0.43) ACACBKIF18A
SCHEMBL22116346 0.81 KIF18A (0.50) KIF18A
SCHEMBL22116413 0.81 HPGD (0.39) ACACBTYK2KIF18A
SCHEMBL22116332 0.78 HSD11B1 (0.44) ACACBKIF18A
SCHEMBL30611713 0.78 PTGER4 (0.42) KIF18A
SCHEMBL22116307 0.78 KIF18A (0.42) ACACBTYK2KIF18A
SCHEMBL30611793 0.78 KIF18A (0.42) ACACBTYK2KIF18A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3897832-A1 N-(PYRIDIN-2-YLSULFONYL)CYCLOPROPANECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF A CFTR MEDIATED DISEASE Novartis AG (CH) 2021-10-27 — — EP disclosed
WO-2020128768-A1 N-(PYRIDIN-2-YLSULFONYL)CYCLOPROPANECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF A CFTR MEDIATED DISEASE NOVARTIS AG (CH) 2020-06-25 — — WO disclosed
Send feedback